Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation

Jason K. Molitoris; Yuan James Rao; Rajal A. Patel; Liam T. Kane; Shahed N. Badiyan; Haley Gittleman; Jill S. Barnholtz-Sloan; Soren M. Bentzen; Tim J. Kruser; Jiayi Huang; Minesh P. Mehta

doi:10.1007/s11060-017-2529-2

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation

Jason K. Molitoris, Yuan James Rao, Rajal A. Patel, Liam T. Kane, Shahed N. Badiyan, Haley Gittleman, Jill S. Barnholtz-Sloan, Soren M. Bentzen, Tim J. Kruser, Jiayi Huang, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	134
DOIs	https://doi.org/10.1007/s11060-017-2529-2
State	Published - Sep 1 2017

Disciplines

Pathology
Medicine and Health Sciences
Surgery

Access to Document

10.1007/s11060-017-2529-2License: Unspecified

Cite this

@article{4d864ec4f59744b5b645ccf2bf1b08d2,

title = "Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation",

author = "Molitoris, \{Jason K.\} and Rao, \{Yuan James\} and Patel, \{Rajal A.\} and Kane, \{Liam T.\} and Badiyan, \{Shahed N.\} and Haley Gittleman and Barnholtz-Sloan, \{Jill S.\} and Bentzen, \{Soren M.\} and Kruser, \{Tim J.\} and Jiayi Huang and Mehta, \{Minesh P.\}",

note = "A recent nomogram for glioblastoma (GBM) was designed to incorporate methylguanine-DNA methyltransferase (MGMT) methylation status in trial patients receiving temozolomide. Since clinical trial patients are strictly selected, compared to the general population, we performed a multi-institutional, external, independent assessment of the nomogram.",

year = "2017",

month = sep,

day = "1",

doi = "10.1007/s11060-017-2529-2",

language = "American English",

volume = "134",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation

AU - Molitoris, Jason K.

AU - Rao, Yuan James

AU - Patel, Rajal A.

AU - Kane, Liam T.

AU - Badiyan, Shahed N.

AU - Gittleman, Haley

AU - Barnholtz-Sloan, Jill S.

AU - Bentzen, Soren M.

AU - Kruser, Tim J.

AU - Huang, Jiayi

AU - Mehta, Minesh P.

N1 - A recent nomogram for glioblastoma (GBM) was designed to incorporate methylguanine-DNA methyltransferase (MGMT) methylation status in trial patients receiving temozolomide. Since clinical trial patients are strictly selected, compared to the general population, we performed a multi-institutional, external, independent assessment of the nomogram.

PY - 2017/9/1

Y1 - 2017/9/1

UR - https://link.springer.com/content/pdf/10.1007%2Fs11060-017-2529-2.pdf

U2 - 10.1007/s11060-017-2529-2

DO - 10.1007/s11060-017-2529-2

M3 - Article

VL - 134

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation

Disciplines

Access to Document

Other files and links

Cite this